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We hypothesize that the femoral I/R vein will show an increase in blood H2O2 
release compared to its counterpart sham femoral vein. Whereas, a decrease 
in NO release is expected in the femoral I/R vein compared to the sham vein 
of saline control animals. When the direct NADPH oxidase inhibitor, apocynin 
(T1/2 3h), is given at the beginning of reperfusion we predict a decrease in 
H2O2 release and an increase in endothelial-derived NO bioavailability 
compared to saline control group.  
When apocynin is given at the beginning of reperfusion, there is a significant 
reduction of blood H2O2 and a significant increase in endothelial-derived NO 
bioavailablity compared to the saline group. Apocynin has reportedly been 
successful in preventing Cys196 interaction between the  endothelial NADPH 
oxidase subunits p47phox and p22phox, which is necessary for NADPH oxidase 
assembly at the cell membrane. By preventing NADPH oxidase assembly 
under I/R conditions, SO production should decrease, thus leading to a 
decrease in H2O2 and an increase of endothelial-derived NO bioavailability. 
This inhibition appears to be consistent with our findings, suggesting that 
endothelial NADPH oxidase is a major contributor to oxidative stress in this 
model of I/R injury since only resident leukocytes are present during this time 
course. 
We measured H2O2 or NO release in real-time from femoral veins of the 
anesthetized rat: one limb subjected to I/R while the other was used as a 
non-ischemic sham control. The H2O2 or NO microsensors (100 um, WPI 
inc.) were connected to a free radical analyzer (Apollo 4000, WPI inc.) and 
were inserted into a catheter placed inside each femoral vein. Ischemia of 
femoral circulation in one limb was induced by clamping the femoral 
artery/vein for 20 minutes followed by 45 minutes of reperfusion. Apocynin 
(13.7 mg/kg, diluted in saline ~ 1 mM in blood) or saline (for non-drug 
control group) was administered through a juglar vein cannulation at the 
beginning of reperfusion. Experimental groups were compared with student t-
test.  
 
Figure 6. Comparison of the relative difference in H2O2 release between I/R 
and sham femoral veins during reperfusion. There was a significant 
decrease in H2O2 release in the apocynin-treated group compared to saline 
from 20 minutes to 45 minutes of reperfusion (* p<0.05, **p<0.01 from 
saline).   
Figure 4. The experimental preparation for measuring H2O2 or NO release 
from male Sprague-Dawley rats (275-325 grams, Ace Animals, Boyertown, 
PA) femoral veins. 
Hypothesis 
Figure 7. Comparison of the relative difference in NO bioavailability between 
I/R and sham femoral veins during reperfusion.  There was a significant 
increase in NO release in the apocynin-treated group compared to saline 
from 20 minutes to 45 minutes of reperfusion (* p<0.05, **p<0.01 from 
saline).  
Vascular endothelial dysfunction can initiate oxidative stress, i.e. 
superoxide (SO) overproduction, during ischemia/reperfusion (I/R). 
Endothelial dysfunction is characterized by an increase of oxidative stress, 
leading to an increase in blood hydrogen peroxide (H2O2) and a decrease 
in endothelial-derived nitric oxide (NO) bioavailability. Leukocyte NADPH 
oxidase is well studied; however, endothelial NADPH oxidase contributing 
to I/R injury is not well characterized. Previous studies using Gö 6983, a 
broad-spectrum protein kinase C inhibitor that can inhibit NADPH oxidase 
activity, has attenuated blood H2O2 levels during femoral I/R in vivo (1,2). A 
selective NADPH oxidase inhibitor, apocynin (Fig. 1), interrupts the 
intracellular assembly of the enzyme by preventing the translocation to the 
cell membrane (Fig. 2). Specifically, apocynin blocks the Cys196 residue 
interaction between endothelial NADPH oxidase subunits p47phox and p22phox 
(Fig. 3). This in turn inhibits SO release from endothelial NADPH oxidase, 
which further enhances endothelial-derived NO release both of which may 
reduce oxidative stress in I/R injury (3,4).   
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Figure 2. Apocynin inhibits endothelial NADPH oxidase subunits p47phox and 
p22phox assembly, preventing the production of SO.  Adapted from Morena M 
et al. 2002 (5). 
Figure 1. Apocynin (acetovallinone) molecular structure. Molar Mass: 166.2. 
T1/2 of hours. Sigma Chemicals. 
Figure 3. Apocynin interrupts the Cys196 interaction between NADPH oxidase 
subunits p47phox and p22phox, preventing enzyme assembly and SO 
generation. Adapted from Mora-Pale et al, 2012 (4). 
We continuously recorded the H2O2 or NO release and collected the data at 5 
minute intervals  during a 15 minute baseline period, 20 minute ischemia and 
45 minute reperfusion. The changes in H2O2 or NO release during I/R (in pA) 
were expressed as relative change to baseline H2O2 (uM) or NO (nM) after 
correction to the calibration curve of H2O2 or NO microsensors.  
Results 
Figure 5. The time course of change in H2O2 (uM) or NO (nM) release from 
femoral veins during reperfusion in the saline control group.  
(a) There was a significant increase in H2O2 release from I/R veins compared 
to sham veins during reperfusion (* p<0.05, **p<0.01 from sham).  
(b)  There was no significant difference in NO release from I/R veins 
compared to sham during reperfusion (* p<0.05, **p<0.01 from sham).  
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